Prevalence of suspected hypertrophic cardiomyopathy or left ventricular hypertrophy based on race and gender in teenagers using screening echocardiography

Cardiovascular Ultrasound

Volumn 8, Issue 1, 2010, Pages

  Movahed, Mohammad Reza ^a,b   Strootman, Deborah ^a   Bates, Sharon ^c   Sattur, Sudhakar ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^c Anthony Bates Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ETHNICITY; FEMALE; GENDER; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RACE; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; COMORBIDITY; ECHOGRAPHY; MASS SCREENING; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; STATISTICS; UNITED STATES;

ADOLESCENT; ARIZONA; CARDIOMYOPATHY, HYPERTROPHIC; COMORBIDITY; CONTINENTAL POPULATION GROUPS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MASS SCREENING; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 78651412178     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-8-54     Document Type: Article

References (23)

1. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. BJ Maron WC Roberts SE Epstein, Circulation 1982 65 7 1388 1394 7200406
2. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. BJ Maron I Olivotto P Spirito SA Casey P Bellone TE Gohman KJ Graham DA Burton F Cecchi, Circulation 2000 102 8 858 864 10952953
3. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. BJ Maron JM Gardin JM Flack SS Gidding TT Kurosaki DE Bild, Coronary Artery Risk Development in (Young) Adults. Circulation 1995 92 4 785 789
4. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. BJ Maron WJ McKenna GK Danielson LJ Kappenberger HJ Kuhn CE Seidman PM Shah WH Spencer P Spirito FJ Ten Cate ED Wigle, J Am Coll Cardiol 2003 42 9 1687 1713 10.1016/S0735-1097(03)00941-0 14607462 (Pubitemid 37383745)
5. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. BJ Maron EE Peterson MS Maron JE Peterson, Am J Cardiol 1994 73 8 577 580 10.1016/0002-9149(94)90337-9 8147304
6. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. BJ Maron A Pelliccia P Spirito, Circulation 1995 91 5 1596 1601 7867202
7. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. P Palka A Lange AD Fleming JE Donnelly DP Dutka IR Starkey TR Shaw GR Sutherland KA Fox, J Am Coll Cardiol 1997 30 3 760 768 10.1016/S0735-1097(97)00231-3 9283537
8. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. A Pelliccia BJ Maron A Spataro MA Proschan P Spirito, N Engl J Med 1991 324 5 295 301 10.1056/NEJM199101313240504 1824720
9. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. PM Elliott J Poloniecki S Dickie S Sharma L Monserrat A Varnava NG Mahon WJ McKenna, J Am Coll Cardiol 2000 36 7 2212 2218 10.1016/S0735-1097(00) 01003-2 11127463
10. Hypertrophic cardiomyopathy in South African Blacks. BS Lewis NE Agathangelou H Flax MA Taams JB Barlow, S Afr Med J 1983 63 8 266 270 6681681
11. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. BJ Maron P Spirito, Am J Cardiol 1993 72 12 970 972 10.1016/0002-9149(93)91117-Z 8213558
12. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. BJ Maron KP Carney HM Lever JF Lewis I Barac SA Casey MV Sherrid, J Am Coll Cardiol 2003 41 6 974 980 10.1016/S0735-1097(02) 02976-5 12651044
13. Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks. AP Burke A Farb J Pestaner GT Malcom A Zieske R Kutys J Smialek R Virmani, Circulation 2002 105 4 419 424 10.1161/hc0402.102952 11815422
14. Race and the decision to refer for coronary revascularization: the effect of physician awareness of patient ethnicity. S Okelo AL Taylor JT Wright Jr N Gordon G Mohan E Lesnefsky, J Am Coll Cardiol 2001 38 3 698 704 10.1016/S0735-1097(01)01418-8 11527620
15. The effect of race and sex on physicians' recommendations for cardiac catheterization. KA Schulman JA Berlin W Harless JF Kerner S Sistrunk BJ Gersh R Dube CK Taleghani JE Burke S Williams JM Eisenberg JJ Escarce, N Engl J Med 1999 340 8 618 626 10.1056/NEJM199902253400806 10029647
16. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. S Basavarajaiah A Boraita G Whyte M Wilson L Carby A Shah S Sharma, J Am Coll Cardiol 2008 51 23 2256 2262 10.1016/j.jacc.2007.12.061 18534273
17. Physiologic left ventricular cavity dilatation in elite athletes. A Pelliccia F Culasso FM Di Paolo BJ Maron, Ann Intern Med 1999 130 1 23 31 9890846
18. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. A Pelliccia FM Di Paolo D Corrado C Buccolieri FM Quattrini C Pisicchio A Spataro A Biffi M Granata BJ Maron, Eur Heart J 2006 27 18 2196 2200 10.1093/eurheartj/ehl137 16831826
19. The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey. F Cecchi I Olivotto S Betocchi C Rapezzi MR Conte G Sinagra E Zachara A Gavazzi R Rordorf G Carnemolla M Porcu S Nistri P Gruppillo S Giampaoli, Am Heart J 2005 150 5 947 954 10.1016/j.ahj.2005.01.005 16290970
20. Left ventricular hypertrophy in Caucasian master athletes: Differences with hypertension and hypertrophic cardiomyopathy. G Limongelli M Verrengia G Pacileo A Da Ponte P Brancaccio R Canonico A D'Andrea B Sarubbi F Cerasuolo R Calabro FM Limongelli, Int J Cardiol 2006 111 1 113 119 10.1016/j.ijcard.2005. 07.033 16260052
21. Screening for hypertrophic cardiomyopathy in young athletes. D Corrado C Basso M Schiavon G Thiene, N Engl J Med 1998 339 6 364 369 10.1056/ NEJM199808063390602 9691102
22. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. S Basavarajaiah M Wilson G Whyte A Shah W McKenna S Sharma, J Am Coll Cardiol 2008 51 10 1033 1039 10.1016/j.jacc.2007.10.055 18325444
23. Ethical authorship and publishing. AJ Coats, Int J Cardiol 2009 131 2 149 150 10.1016/j.ijcard.2008.11.048 19046787